GOOD DISTRIBUTION PRACTICES (GDP) FOR …
The document lays down guidelines for the distribution of pharmaceutical products . This document does not cover materials such as pharmaceutical starting materials (active pharmaceutical ingredients (API) and excipients), reagents, solvents, process aids, intermediate products, packaging materials and labelling materials.
Download GOOD DISTRIBUTION PRACTICES (GDP) FOR …
Information
Domain:
Source:
Link to this page:
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Related documents
FDA Regulation of Pharmaceutical Marketing
www.ehcca.com• Both products approved for indication studied • Comparable patient populations • Doses consistent with PI and in same part of dosage range • Comparisons of clinically meaningful endpoints • Formulation identical to U.S. formulation • Two adequate and well-controlled studies
Analysis of Extractables & Leachables in Pharmaceutical ...
www.agilent.com#1 QA/QC for small molecule drug products #2 QA/QC for bio-pharmaceutical drug products #3 QA/QC for packaging materials #4 QA/QC in CMOs #5 CROs #6 Other Question #2 How strong is the risk for one of your products getting recalled due to a contamination with harmful E&Ls? Answers #1 low, everything under control #2 medium #3 high
Guideline on the requirements to the chemical and ...
www.ema.europa.euCommittee for Medicinal Products for Human Use (CHMP)3 4 Guideline on the requirements to the chemical and 5 pharmaceutical quality documentation concerning 6 . investigational medicinal products in clinical trials . 7 . Draft . Draft agreed by Quality Working Party
Guideline on Inhalational medicinal products
www.ema.europa.euPharmaceutical development studies are conducted to establish that the dosage form, formulation, manufacturing process, container closure system, microbiological attributes and instructions for use are appropriate and result in acceptable product performance.
ASEAN Variation Guidelines For Pharmaceutical Products
www.fda.gov.phASEAN Variation Guideline for Pharmaceutical Products (R1) i LIST OF CONTENTS Page 1 INTRODUCTION 1 2 SCOPE OF THIS GUIDELINE 1 3 Definition 1 3.1 Major Variation (MaV) 1 3.2 Minor Variation (MiV-PA & MiV-N) 1 4 PROCEDURE AND TIMELINE 2-3 5 CHANGES LEADING TO A NEW PRODUCT REGISTRATION 3 6 OTHERS 3 7 MAJOR VARIATION (MaV)
ISSN: 2231 Stability Testing of Pharmaceutical Products
www.japsonline.comStability testing of pharmaceutical products is a complex set of procedures involving considerable cost, time consumption and scientific expertise in order to build in quality, efficacy and safety in a drug formulation. Scientific and commercial success of a pharmaceutical product
Annex 5 Guidelines for stability testing of pharmaceutical ...
www.paho.orgThe stability of finished pharmaceutical products depends, on the one hand, on environmental factors such as ambient temperature, humidity and light, and, on the other, on product-related factors, e.g. the chemical and physical properties of the active substance and of pharmaceutical excipients, the dosage form and its composition, the
Annex 9 Guidelines on packaging for pharmaceutical …
www.who.intpharmaceutical products should ensure that “arrangements are made for the manufacture, supply and use of the correct starting and pack-aging materials” (1). Public opinion sometimes considers packaging to be superfluous. However, it must be emphasized that packaging preserves the stabil-